Cargando…
Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer
Background: High tumor mutational burden (TMB-H) has been reported as a predictive marker to immunotherapy or prognostic marker in various tumor types. However, there has been little study of the role of TMB-H in advanced biliary tract cancer (BTC). Methods: We analyzed 119 advanced BTC patients who...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646759/ https://www.ncbi.nlm.nih.gov/pubmed/34855561 http://dx.doi.org/10.1177/15330338211062324 |